There are 290 million people with cardiovascular diseases in China now and cardiovascular disease has become the cause of over 40 percent of deaths in the nation, experts told the Oriental Congress of Cardiology over the weekend.

To enhance disease prevention and control, China Cardiovascular Health Association, a charity platform of cardiovascular disease in China, signed agreement with world-leading pharmaceutical company Pfizer during the congress to help build grassroots chronic disease management and chest pain centers to extend disease prevention and treatment network to county-based health authorities.

Professional trainings for medical staff and cardiovascular health management based big data are also included into the program.